Development of bioreactor scale-down model using orthogonal projections to latent structures method and CO2

Jinxin Gao1, Laurie B Hazeltine2, Neal Stroud3

  • 1Statistics, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA.

Biotechnology Progress
|January 30, 2024
PubMed
Summary

Qualifying scale-down models using orthogonal projections to latent structures (OPLS) analysis improves cell culture process understanding. This novel method identified critical process parameter differences, enhancing scale-up consistency and product quality.

Related Concept Videos